Nix Biosensors
Nix Biosensors Raises $10M Series A for Hydration Intelligence
Nix Biosensors announced $10M in Series A financing on September 15, 2026. Nix Biosensors closed a $10 million Series A to develop Nix Health and bring personalized hydration data into consumer-health platforms.
Round details
The financing includes backing from Shorewind Capital, Great Oaks Venture Capital, White Road Investments, Anne Wojcicki. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $10M
- Total funding reported: $17M
- Headquarters: Boston, MA
How the company plans to use the capital
Nix will fund product development, data science, and market expansion, with a focus on Nix Health algorithms that can be licensed into existing consumer-health platforms without requiring a sweat sensor.
Why this matters for GTM teams
The financing points to a broader commercialization path for wearable data: converting proprietary real-world datasets into software intelligence that can travel across consumer-health platforms.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Nix Biosensors Series A announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


